The Pharmacy Quality Alliance (PQA) is seeking comments on its “Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models.” This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
Included in the proposal are measure concepts relevant to community and specialty pharmacy. The PQA intends to develop the measures with a time-focused approach based on practical deadlines for measure availability for upcoming Medicare plan years.
The proposal was developed by the consensus achieved in a PQA workshop that included community pharmacy, specialty pharmacy, health plan, pharmacy benefit management, and association representatives. Once developed, the measures could be used in value-based models in Medicare Part D and other programs.
In a prepared statement, Laura Cranston, RPh, PQA Chief Executive Officer, emphasized the importance of this proposal.
“PQA stakeholders recognize an expanding role for community pharmacists that can be measured. Pharmacy clinical services and the measures that document them are an important direction for PQA’s measure set in the medium and long term," said Cranston.
PQA member and public comments will be accepted through September 6 at 5:00 pm ET via a form on the PQA website.
Reference
PQA seeks comments on proposed standard measure set for pharmacy accountability in value-based models [news release]. Alexandria, VA: Pharmacy Quality Alliance; August 22, 2019. https://www.pqaalliance.org/measure-set-comment-period. Accessed August 23, 2019.
Article
Comments Sought on Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models
Author(s):
This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
The Pharmacy Quality Alliance (PQA) is seeking comments on its “Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models.” This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
Included in the proposal are measure concepts relevant to community and specialty pharmacy. The PQA intends to develop the measures with a time-focused approach based on practical deadlines for measure availability for upcoming Medicare plan years.
The proposal was developed by the consensus achieved in a PQA workshop that included community pharmacy, specialty pharmacy, health plan, pharmacy benefit management, and association representatives. Once developed, the measures could be used in value-based models in Medicare Part D and other programs.
In a prepared statement, Laura Cranston, RPh, PQA Chief Executive Officer, emphasized the importance of this proposal.
“PQA stakeholders recognize an expanding role for community pharmacists that can be measured. Pharmacy clinical services and the measures that document them are an important direction for PQA’s measure set in the medium and long term," said Cranston.
PQA member and public comments will be accepted through September 6 at 5:00 pm ET via a form on the PQA website.
Reference
PQA seeks comments on proposed standard measure set for pharmacy accountability in value-based models [news release]. Alexandria, VA: Pharmacy Quality Alliance; August 22, 2019. https://www.pqaalliance.org/measure-set-comment-period. Accessed August 23, 2019.
Expert Q&A: Role of Pharmacists in COVID-19 Care, Prevention Continues to Evolve
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
Herpes Zoster as an Early Indicator of HIV: Clinical Insights
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
ACC 2025: Semaglutide Significantly Improves Walking Distance, Symptoms, QOL for Individuals with PAD and Diabetes
Novo Nordisk Expands Semaglutide Access With Discounted Pricing
Expert Q&A: Role of Pharmacists in COVID-19 Care, Prevention Continues to Evolve
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
Herpes Zoster as an Early Indicator of HIV: Clinical Insights
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
ACC 2025: Semaglutide Significantly Improves Walking Distance, Symptoms, QOL for Individuals with PAD and Diabetes
Novo Nordisk Expands Semaglutide Access With Discounted Pricing